# Anaptysbio, Inc: Form 8-K, filed Feb 3, 2025

- Company: [Anaptysbio, Inc](/companies/anab.md) (CIK 1370053)
- Form: 8-K
- Filed: 2025-02-03
- Accepted by EDGAR: Feb 3, 2025, 13:55 ET
- Period: 2025-01-31
- Accession: 0001370053-25-000002
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1370053/000137005325000002/anab-20250131.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1370053/000137005325000002/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1370053/000137005325000002/anab-20250131.htm

Filed Feb 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001370053-25-000002. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.